Potential effector and immunoregulatory functions of mast cells in mucosal immunity

Mucosal Immunology

Volumn 8, Issue 3, 2015, Pages 444-463

  Reber, L L ^a   Sibilano, R ^a   Mukai, K ^a   Galli, S J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; CYTOKINE; IMMUNOGLOBULIN E;

ANAPHYLAXIS; ASTHMA; BACTERIAL INFECTION; CELL ACTIVATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; DISEASE ASSOCIATION; FOOD ALLERGY; HUMAN; IMMUNOREGULATION; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; MAST CELL; MUCOSAL IMMUNITY; NONHUMAN; PARASITOSIS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VIRUS INFECTION; ANIMAL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE INFECTION; MOUSE; MUCOSA; PATHOLOGY; SPECIES DIFFERENCE;

ANAPHYLAXIS; ANIMALS; ASTHMA; CYTOKINES; FOOD HYPERSENSITIVITY; GENE EXPRESSION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN E; INTESTINAL DISEASES, PARASITIC; MAST CELLS; MICE; MUCOUS MEMBRANE; SPECIES SPECIFICITY;

EID: 84928879636     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.131     Document Type: Review

References (380)

1. Mekori, Y.A. & Metcalfe, D.D. Mast cells in innate immunity. Immunol. Rev. 173, 131-140 (2000).
2. Metz, M., Grimbaldeston, M.A., Nakae, S., Piliponsky, A.M., Tsai, M. & Galli, S.J. Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev. 217, 304-328 (2007).
3. Galli, S.J., Grimbaldeston, M. & Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol. 8, 478-486 (2008).
4. Moon, T.C. et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol. 3, 111-128 (2010).
5. Gurish, M.F. & Austen, K.F. Developmental origin and functional specialization of mast cell subsets. Immunity 37, 25-33 (2012).
6. Kalesnikoff, J. & Galli, S.J. New developments in mast cell biology. Nat. Immunol. 9, 1215-1223 (2008).
7. Galli, S.J., Nakae, S. & Tsai, M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135-142 (2005).
8. Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., Piliponsky, A.M., Williams, C.M. & Tsai, M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786 (2005).
9. Kitamura, Y., Shimada, M., Hatanaka, K. & Miyano, Y. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268, 442-443 (1977).
10. Kitamura, Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59-76 (1989).
11. Douaiher, J. et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv. Immunol. 122, 211-252 (2014).
12. Oliveira, S.H. & Lukacs, N.W. Stem cell factor: a hemopoietic cytokine with important targets in asthma. Curr. Drug Targets Inflamm. Allergy 2, 313-318 (2003).
13. Reber, L., Da Silva, C.A. & Frossard, N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur. J. Pharmacol. 533, 327-340 (2006).
14. Galli, S.J., Zsebo, K.M. & Geissler, E.N. The kit ligand, stem cell factor. Adv. Immunol. 55, 1-96 (1994).
15. Razin, E. et al. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132, 1479-1486 (1984).
16. Toru, H., Ra, C., Nonoyama, S., Suzuki, K., Yata, J. & Nakahata, T. Induction of the high-affinity IgE receptor (FceRI) on human mast cells by IL-4. Int. Immunol. 8, 1367-1373 (1996).
17. Valent, P. et al. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc. Natl. Acad. Sci. USA 88, 3339-3342 (1991).
18. Sillaber, C. et al. IL-4 regulates c-kit proto-oncogene product expression in humanmast andmyeloid progenitor cells. J. Immunol. 147, 4224-4228 (1991).
19. Toru, H., Eguchi, M., Matsumoto, R., Yanagida, M., Yata, J. & Nakahata, T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91, 187-195 (1998).
20. Matsuzawa, S., Sakashita, K., Kinoshita, T., Ito, S., Yamashita, T. & Koike, K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J. Immunol. 170, 3461-3467 (2003).
21. Mwamtemi, H.H. et al. An increase in circulating mast cell colony-forming cells in asthma. J. Immunol. 166, 4672-4677 (2001).
22. Bailey, D.P., Kashyap, M., Bouton, L.A., Murray, P.J. & Ryan, J.J. Interleukin-10 induces apoptosis in developing mast cells and macrophages. J. Leukoc. Biol. 80, 581-589 (2006).
23. Royer, B., Varadaradjalou, S., Saas, P., Guillosson, J.J., Kantelip, J.P. & Arock, M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31, 694-704 (2001).
24. Yeatman, C.F. II et al. Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J. Exp. Med. 192, 1093-1103 (2000).
25. Ho, L.H. et al. IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc∈RI signals. J. Leukoc. Biol. 82, 1481-1490 (2007).
26. Iikura, M. et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87, 971-978 (2007).
27. Allakhverdi, Z., Smith, D.E., Comeau, M.R. & Delespesse, G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179, 2051-2054 (2007).
28. Lin, T.J., Issekutz, T.B. & Marshall, J.S. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1α. J. Immunol. 165, 211-220 (2000).
29. 4 histamine receptormediates optimal migration ofmast cell precursors to CXCL12. J. Allergy Clin. Immunol. 120, 827-834 (2007).
30. Macey, M.R. et al. IL-4 and TGF-β1 counterbalance one another while regulating mast cell homeostasis. J. Immunol. 184, 4688-4695 (2010).
31. Matsuda, H. et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 174, 7-14 (1991).
32. Ruitenberg, E.J. & Elgersma, A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature 264, 258-260 (1976).
33. Friend, D.S., Ghildyal, N., Austen, K.F., Gurish, M.F., Matsumoto, R. & Stevens, R.L. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J. Cell Biol. 135, 279-290 (1996).
34. Friend, D.S. et al. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis. J. Immunol. 160, 5537-5545 (1998).
35. Hunt, J.E., Stevens, R.L., Austen, K.F., Zhang, J., Xia, Z. & Ghildyal, N. Natural disruption of the mousemast cell protease 7 gene in the C57BL/6 mouse. J. Biol. Chem. 271, 2851-2855 (1996).
36. Jippo, T., Lee, Y.M., Ge, Y., Kim, D.K., Okabe, M. & Kitamura, Y. Tissuedependent alteration of protease expression phenotype in murine peritoneal mast cells that were genetically labeled with green fluorescent protein. Am. J. Pathol. 158, 1695-1701 (2001).
37. Galli, S.J., Borregaard, N. & Wynn, T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12, 1035-1044 (2011).
38. Irani, A.M., Bradford, T.R., Kepley, C.L., Schechter, N.M. & Schwartz, L.B. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37, 1509-1515 (1989).
39. Li, L., Meng, X.W. & Krilis, S.A. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. J. Immunol. 156, 4839-4844 (1996).
40. Weidner, N. & Austen, K.F. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol. Res. Pract. 189, 156-162 (1993).
41. Irani, A.M., Craig, S.S., De Blois, G., Elson, C.O., Schechter, N.M. & Schwartz, L.B. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J. Immunol. 138, 4381-4386 (1987).
42. Irani, A. A., Schechter, N. M., Craig, S. S., De Blois, G. & Schwartz, L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83, 4464-4468 (1986).
43. Matin, R., Tam, E.K., Nadel, J.A. & Caughey, G.H. Distribution of chymase-containing mast cells in human bronchi. J. Histochem. Cytochem. 40, 781-786 (1992).
44. Bischoff, S.C. Physiological and pathophysiological functions of intestinal mast cells. Semin. Immunopathol. 31, 185-205 (2009).
45. Bischoff, S.C. et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28, 1-13 (1996).
46. Raithel, M., Winterkamp, S., Pacurar, A., Ulrich, P., Hochberger, J. & Hahn, E.G. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 36, 174-179 (2001).
47. Cho, E.Y. et al. Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis. Int. Immunopharmacol. 11, 412-417 (2011).
48. Brandt, E.B. et al. Mast cells are required for experimental oral allergeninduced diarrhea. J. Clin. Invest. 112, 1666-1677 (2003).
49. Hagel, A.F. et al. Mast cell tryptase levels in gut mucosa in patients with gastrointestinal symptoms caused by food allergy. Int. Arch. Allergy Immunol. 160, 350-355 (2013).
50. Betts, C.J. & Else, K.J. Mast cells, eosinophils and antibody-mediated cellular cytotoxicity are not critical in resistance to Trichuris muris. Parasite Immunol. 21, 45-52 (1999).
51. Lantz, C.S. et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93 (1998).
52. Marone, G., Triggiani, M. & de Paulis, A. Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol. 26, 25-31 (2005).
53. Brightling, C.E., Bradding, P., Symon, F.A., Holgate, S.T., Wardlaw, A.J. & Pavord, I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl. J. Med. 346, 1699-1705 (2002).
54. Brightling, C.E., Symon, F.A., Birring, S.S., Bradding, P., Wardlaw, A.J. & Pavord, I.D. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 58, 528-532 (2003).
55. Yu, M., Tsai, M., Tam, S.Y., Jones, C., Zehnder, J. & Galli, S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 116, 1633-1641 (2006).
56. Yu, M. et al. Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J. Clin. Invest. 121, 3133-3143 (2011).
57. Kawanami, O., Ferrans, V.J., Fulmer, J.D. & Crystal, R.G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40, 717-734 (1979).
58. Edwards, S.T. et al. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J. Pathol. 206, 279-290 (2005).
59. Yoshizaki, A. et al. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am. J. Pathol. 172, 1650-1663 (2008).
60. Reber, L.L., Daubeuf, F., Pejler, G., Abrink, M. & Frossard, N. Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism. J. Immunol. 192, 1847-1854 (2014).
61. v mice that genetically lack mast cells. J. Exp. Med. 160, 138-151 (1984).
62. Kanakura, Y. et al. Multiple bidirectional alterations of phenotype and changes in proliferative potential during the in vitro and in vivo passage of clonal mast cell populations derived from mouse peritoneal mast cells. Blood 72, 877-885 (1988).
63. Tsai, M. et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174, 125-131 (1991).
64. Dvorak, A.M., Mihm, M.C. Jr. & Dvorak, H.F. Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab. Invest. 34, 179-191 (1976).
65. Dahlin, J.S. & Hallgren, J. Mast cell progenitors: origin, development and migration to tissues. Mol. Immunol. 63, 9-17 (2014).
66. Arinobu, Y. et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. USA 102, 18105-18110 (2005).
67. Jones, T.G. et al. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J. Immunol. 183, 5251-5260 (2009).
68. Abramson, J. & Pecht, I. Regulation of the mast cell response to the type 1 Fce receptor. Immunol. Rev. 217, 231-254 (2007).
69. Galli, S.J. & Tsai, M. IgE and mast cells in allergic disease. Nat. Med. 18, 693-704 (2012).
70. Reber, L.L. & Frossard, N. Targeting mast cells in inflammatory diseases. Pharmacol. Ther. 142, 416-435 (2014).
71. Turner, H. & Kinet, J.P. Signalling through the high-affinity IgE receptor Fc∈RI. Nature 402, B24-B30 (1999).
72. Rivera, J., Fierro, N.A., Olivera, A. & Suzuki, R. New insights on mast cell activation via the high affinity receptor for IgE. Adv. Immunol. 98, 85-120 (2008).
73. Cheng, L.E., Hartmann, K., Roers, A., Krummel, M.F. & Locksley, R.M. Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E. Immunity 38, 166-175 (2013).
74. Suzuki, R. et al. Molecular editing of cellular responses by the high-affinity receptor for IgE. Science 343, 1021-1025 (2014).
75. Marichal, T. et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 39, 963-975 (2013).
76. Palm, N.W., Rosenstein, R.K., Yu, S., Schenten, D.D., Florsheim, E. & Medzhitov, R. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 39, 976-985 (2013).
77. Palm, N.W., Rosenstein, R.K. & Medzhitov, R. Allergic host defences. Nature 484, 465-472 (2012).
78. Profet, M. The function of allergy: immunological defense against toxins. Q Rev. Biol. 66, 23-62 (1991).
79. Abraham, S.N. & St John, A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10, 440-452 (2010).
80. Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351-1359 (2002).
81. Metz, M. et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 313, 526-530 (2006).
82. Akahoshi, M. et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide inmice. J. Clin. Invest. 121, 4180-4191 (2011).
83. Schneider, L.A., Schlenner, S.M., Feyerabend, T.B., Wunderlin, M. & Rodewald, H.R. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J. Exp. Med. 204, 2629-2639 (2007).
84. Ali, H. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol. Lett. 128, 36-45 (2010).
85. Schafer, B. et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J. Allergy Clin. Immunol. 131, 541-548. e1-9 (2013).
86. Kajiwara, N. et al. Activation of human mast cells through the plateletactivating factor receptor. J. Allergy Clin. Immunol. 125, 1137-1145. e1136 (2010).
87. Metz, M., Gilles, S., Geldmacher, A., Behrendt, H., Traidl-Hoffmann, C. & Maurer, M. Evidence for non-allergic mast cell activation in pollenassociated inflammation. J. Invest. Dermatol. 131, 987-990 (2011).
88. Cirino, G. et al. Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J. Clin. Invest. 99, 2446-2451 (1997).
89. Cirino, G., Cicala, C., Bucci, M.R., Sorrentino, L., Maraganore, J.M. & Stone, S.R. Thrombin functions as an inflammatory mediator through activation of its receptor. J. Exp. Med. 183, 821-827 (1996).
90. Enoksson, M., Lyberg, K., Moller-Westerberg, C., Fallon, P.G., Nilsson, G. & Lunderius-Andersson, C. Mast cells as sensors of cell injury through IL-33 recognition. J. Immunol. 186, 2523-2528 (2011).
91. Lunderius-Andersson, C., Enoksson, M. & Nilsson, G. Mast cells respond to cell injury through the recognition of IL-33. Front. Immunol. 3, 82 (2012).
92. Kaur, D. et al. Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin. Chest 142, 76-85 (2011).
93. Zhou, Y. et al. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 121, 3195-3204 (2013).
94. Sibilano, R. et al. The aryl hydrocarbon receptormodulates acute and late mast cell responses. J. Immunol. 189, 120-127 (2012).
95. Pawankar, R., Okuda, M., Yssel, H., Okumura, K. & Ra, C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc∈RI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99, 1492-1499 (1997).
96. Nakae, S. et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol. 176, 2238-2248 (2006).
97. Kashiwakura, J., Yokoi, H., Saito, H. & Okayama, Y. Tcell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173, 5247-5257 (2004).
98. Sibilano, R. et al. Modulation of Fc∈RI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. J. Allergy Clin. Immunol. 130, 751-760. e752 (2012).
99. Lee, H. et al. Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcg receptor I and Fcγ receptor II. Arthritis Rheum. 65, 109-119 (2013).
100. Malbec, O. & Daeron, M. The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 217, 206-221 (2007).
101. Fantozzi, R. et al. Mast cell and neutrophil interactions: a role for superoxide anion and histamine. Agents Actions 16, 260-264 (1985).
102. Gri, G. et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29, 771-781 (2008).
103. Gaudenzio, N., Espagnolle, N., Mars, L.T., Liblau, R., Valitutti, S. & Espinosa, E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood 114, 4979-4988 (2009).
104. Karra, L. & Levi-Schaffer, F. Down-regulation of mast cell responses through ITIM containing inhibitory receptors. Adv. Exp. Med. Biol. 716, 143-159 (2011).
105. Katz, H.R. Inhibitory receptors and allergy. Curr. Opin. Immunol. 14, 698-704 (2002).
106. Ott, V.L. & Cambier, J.C. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J. Allergy Clin. Immunol. 106, 429-440 (2000).
107. Hill, P.B., MacDonald, A.J., Thornton, E.M., Newlands, G.F., Galli, S.J. & Miller, H.R. Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 87, 326-333 (1996).
108. Ito, T. et al. Stem cell factor programs the mast cell activation phenotype. J. Immunol. 188, 5428-5437 (2012).
109. Komai-Koma, M. et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 67, 1118-1126 (2012).
110. Okayama, Y., Kirshenbaum, A.S. & Metcalfe, D.D. Expression of a functional high-affinity IgG receptor, FcgRI, on human mast cells: upregulation by IFN-γ. J. Immunol. 164, 4332-4339 (2000).
111. Riley, J.F. Histamine in tissue mast cells. Science 118, 332 (1953).
112. Razin, E. et al. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, b-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J. Exp. Med. 157, 189-201 (1983).
113. Windelborg Nielsen, B., Engberg, T.M., Herlin, T., Bjerke, T. & Schiotz, P.O. Histamine release from cord blood basophils. Int. Arch. Allergy Appl. Immunol. 93, 314-322 (1990).
114. Ghosh, A.K., Hirasawa, N., Ohtsu, H., Watanabe, T. & Ohuchi, K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195, 973-982 (2002).
115. Xu, X. et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J. Exp. Med. 203, 2907-2917 (2006).
116. Caughey, G.H. Mast cell proteases as protective and inflammatory mediators. Adv. Exp. Med. Biol. 716, 212-234 (2011).
117. Pejler, G., Ronnberg, E., Waern, I. & Wernersson, S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 115, 4981-4990 (2010).
118. Pejler, G., Abrink, M., Ringvall, M. & Wernersson, S. Mast cell proteases. Adv. Immunol. 95, 167-255 (2007).
119. Huang, C. et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160, 1910-1919 (1998).
120. Compton, S.J., Cairns, J.A., Holgate, S.T. & Walls, A.F. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 161, 1939-1946 (1998).
121. Algermissen, B., Laubscher, J.C., Bauer, F. & Henz, B.M. Purification of mast cell proteases from murine skin. Exp. Dermatol. 8, 413-418 (1999).
122. Compton, S.J., Cairns, J.A., Holgate, S.T. & Walls, A.F. Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC). Clin. Exp. Immunol. 121, 31-36 (2000).
123. Gallwitz, M., Reimer, J.M. & Hellman, L. Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution. Immunogenetics 58, 655-669 (2006).
124. Tchougounova, E., Pejler, G. & Abrink, M. The chymase, mousemast cell protease 4, constitutes themajor chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J. Exp. Med. 198, 423-431 (2003).
125. Andersson, M.K., Karlson, U. & Hellman, L. The extended cleavage specificity of the rodent b-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the humanmast cell chymase. Mol. Immunol. 45, 766-775 (2008).
126. Walsh, L.J., Trinchieri, G., Waldorf, H.A., Whitaker, D. & Murphy, G.F. Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88, 4220-4224 (1991).
127. Frangogiannis, N.G. et al. Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental caninemyocardial ischemia/reperfusion. Circulation 98, 699-710 (1998).
128. Gordon, J.R. & Galli, S.J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346, 274-276 (1990).
129. Kunder, C.A. et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 206, 2455-2467 (2009).
130. Austen, K.F. The mast cell and the cysteinyl leukotrienes. Novartis Found. Symp. 271, 166-175. discussion 176-168, 198-169 (2005).
131. Boyce, J.A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 217, 168-185 (2007).
132. Dreskin, S.C. & Abraham, S.N. Production of TNF-α by murine bone marrow derived mast cells activated by the bacterial fimbrial protein, FimH. Clin. Immunol. 90, 420-424 (1999).
133. Malaviya, R., Ikeda, T., Ross, E. & Abraham, S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77-80 (1996).
134. Gordon, J.R. & Galli, S.J. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc∈RI. Role for mast cellderived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180, 2027-2037 (1994).
135. Burd, P.R. et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170, 245-257 (1989).
136. Hagaman, D.D., Okayama, Y., D'Ambrosio, C., Prussin, C., Gilfillan, A.M. & Metcalfe, D.D. Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge. Am. J. Respir. Cell Mol. Biol. 25, 685-691 (2001).
137. Lin, T.J., Garduno, R., Boudreau, R.T. & Issekutz, A.C. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 a and b. J. Immunol. 169, 4522-4530 (2002).
138. Oldford, S.A., Haidl, I.D., Howatt, M.A., Leiva, C.A., Johnston, B. & Marshall, J.S. A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J. Immunol. 185, 7067-7076 (2010).
139. Liu, J. et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15, 940-945 (2009).
140. Ishizuka, T., Okayama, Y., Kobayashi, H. & Mori, M. Interleukin-10 is localized to and released by human lung mast cells. Clin. Exp. Allergy 29, 1424-1432 (1999).
141. Grimbaldeston, M.A., Nakae, S., Kalesnikoff, J., Tsai, M. & Galli, S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 8, 1095-1104 (2007).
142. Song, C., Zhang, Q., Liu, X. & Shan, Y. IL-12 and IL-10 production are differentially regulated by phosphatidylinositol 3-kinase in mast cells. Scand. J. Immunol. 75, 266-272 (2012).
143. Mrabet-Dahbi, S., Metz, M., Dudeck, A., Zuberbier, T. & Maurer, M. Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol. 18, 437-444 (2009).
144. Buckland, J. New role for mast cells as IL-17-expressing effector cells in established RA. Nat. Rev. Rheumatol. 6, 243 (2010).
145. Hueber, A.J. et al. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 184, 3336-3340 (2010).
146. Boesiger, J. et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fce receptor I expression. J. Exp. Med. 188, 1135-1145 (1998).
147. Grützkau, A. et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell 9, 875-884 (1998).
148. Detoraki, A. et al. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J. Allergy Clin. Immunol. 123, 1142-1149. 1149 e1141-1145 (2009).
149. Zhang, S. et al. Human mast cells express stem cell factor. J. Pathol. 186, 59-66 (1998).
150. de Paulis, A. et al. Stem cell factor is localized in, released from, and cleaved by human mast cells. J. Immunol. 163, 2799-2808 (1999).
151. Sibilano, R., Frossi, B. & Pucillo, C.E. Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur. J. Immunol. 44, 2558-2566 (2014).
152. Reber, L.L., Marichal, T. & Galli, S.J. New models for analyzing mast cell functions in vivo. Trends Immunol. 33, 613-625 (2012).
153. Oka, T., Kalesnikoff, J., Starkl, P., Tsai, M. & Galli, S.J. Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab. Invest. 92, 1472-1482 (2012).
154. Dawicki, W. & Marshall, J.S. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19, 31-38 (2007).
155. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167, 835-848 (2005).
156. Grimbaldeston, M.A., Metz, M., Yu, M., Tsai, M. & Galli, S.J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr. Opin. Immunol. 18, 751-760 (2006).
157. (W-sh mice does not impair antibody-mediated arthritis. J. Exp. Med. 204, 2797-2802 (2007).
158. W-sh/W-sh mice. Am. J. Pathol. 176, 926-938 (2010).
159. sh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173, 1693-1701 (2008).
160. v. J. Cell. Physiol. 73, 25-30 (1969).
161. sh mutation on mouse chromosome 5 is associated with an inversion. Hum. Mol. Genet. 4, 2073-2079 (1995).
162. Lyon, M.F. & Glenister, P.H. A new allele sash (Wsh) at the W-locus and a spontaneous recessive lethal in mice. Genet. Res. 39, 315-322 (1982).
163. W-sh sash mice. Clin. Exp. Allergy 35, 82-88 (2005).
164. Huizinga, J.D., Thuneberg, L., Kluppel, M., Malysz, J., Mikkelsen, H.B. & Bernstein, A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373, 347-349 (1995).
165. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162, 1025-1043 (1985).
166. d mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127, 191-198 (1987).
167. fl/fl mice. Blood 118, 6930-6938 (2011).
168. Dudeck, A. et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34, 973-984 (2011).
169. Scholten, J. et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 17, 307-315 (2008).
170. Musch, W., Wege, A.K., Mannel, D.N. & Hehlgans, T. Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 46, 163-166 (2008).
171. Otsuka, A. et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 6, e25538 (2011).
172. Feyerabend, T.B. et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity. Immunity 35, 832-844 (2011).
173. Furumoto, Y. et al. PTEN deficiency in mast cells causes a mastocytosislike proliferative disease that heightens allergic responses and vascular permeability. Blood 118, 5466-5475 (2011).
174. Rodewald, H.R. & Feyerabend, T.B. Widespread immunological functions of mast cells: fact or fiction? Immunity 37, 13-24 (2012).
175. Galli, S.J., Tsai, M., Marichal, T., Chugunova, E., Reber, L.L. & Pejler, G. Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv. Immunol. (in press).
176. Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14, 478-494 (2014).
177. Groschwitz, K.R. et al. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc. Natl. Acad. Sci. USA 106, 22381-22386 (2009).
178. Berkes, J., Viswanathan, V.K., Savkovic, S.D. & Hecht, G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52, 439-451 (2003).
179. v mice by bone marrow transplantation. J. Clin. Invest. 87, 687-693 (1991).
180. Groschwitz, K.R. & Hogan, S.P. Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124, 3-20. quiz 21-22 (2009).
181. McDermott, J.R., Bartram, R.E., Knight, P.A., Miller, H.R., Garrod, D.R. & Grencis, R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc. Natl. Acad. Sci. USA 100, 7761-7766 (2003).
182. Chabot, B., Stephenson, D.A., Chapman, V.M., Besmer, P. & Bernstein, A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335, 88-89 (1988).
183. 17H mice. Blood 94, 1915-1925 (1999).
184. Wang, L., Stanisz, A.M., Wershil, B.K., Galli, S.J. & Perdue, M.H. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am. J. Physiol. 269, G85-G92 (1995).
185. Bousquet, J., Jeffery, P.K., Busse, W.W., Johnson, M. & Vignola, A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161, 1720-1745 (2000).
186. Fish, J.E. & Peters, S.P. Airway remodeling and persistent airway obstruction in asthma. J. Allergy Clin. Immunol. 104, 509-516 (1999).
187. Wills-Karp, M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17, 255-281 (1999).
188. Busse, W.W. & Lemanske, R.F. Asthma. N Engl. J. Med. 344, 350-362 (2001).
189. Holt, P.G. & Sly, P.D. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat. Med. 18, 726-735 (2012).
190. Wenzel, S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18, 716-725 (2012).
191. Slager, R.E., Hawkins, G.A., Li, X., Postma, D.S., Meyers, D.A. & Bleecker, E.R. Genetics of asthma susceptibility and severity. Clin. Chest Med. 33, 431-443 (2012).
192. Meyers, D.A., Bleecker, E.R., Holloway, J.W. & Holgate, S.T. Asthma genetics and personalised medicine. Lancet Respir. Med. 2, 405-415 (2014).
193. H2-high asthma. J. Allergy Clin. Immunol. 125, 1046-1053. e1048 (2010).
194. Balzar, S. et al. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 183, 299-309 (2011).
195. Carroll, N.G., Mutavdzic, S. & James, A.L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J. 19, 879-885 (2002).
196. Bradley, B.L. et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88, 661-674 (1991).
197. 20AMP in asthma and COPD. Respir. Med. 101, 882-887 (2007).
198. Lamb, D. & Lumsden, A. Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency. Thorax 37, 334-342 (1982).
199. Holgate, S.T., Lackie, P.M., Davies, D.E., Roche, W.R. & Walls, A.F. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin. Exp. Allergy. 29 (Suppl 2), 90-95 (1999).
200. Wilson, J.W. & Bamford, T.L. Assessing the evidence for remodelling of the airway in asthma. Pulm. Pharmacol. Ther. 14, 229-247 (2001).
201. Altin, J., Shen, C. & Liston, A. Understanding the genetic regulation of IgE production. Blood Rev. 24, 163-169 (2010).
202. Takhar, P. et al. Class switch recombination to IgE in the bronchialmucosa of atopic and nonatopic patients with asthma. J. Allergy Clin. Immunol. 119, 213-218 (2007).
203. Williams, C.M. & Galli, S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model inmice. J. Exp. Med. 192, 455-462 (2000).
204. Taube, C. et al. Mast cells, Fc∈RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172, 6398-6406 (2004).
205. H2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120, 48-55 (2007).
206. Reuter, S. et al. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur. Respir. J. 31, 773-782 (2008).
207. Kung, T.T. et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12, 404-409 (1995).
208. Kobayashi, T. et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthmamodel. J. Immunol. 164, 3855-3861 (2000).
209. Nogami, M. et al. Experimental pulmonary eosinophilia in mice by Ascaris suum extract. Am. Rev. Respir. Dis. 141, 1289-1295 (1990).
210. Okudaira, H. et al. T-cell-dependent accumulation of eosinophils in the lung and its inhibition by monoclonal anti-interleukin-5. Int. Arch. Allergy Appl. Immunol. 94, 171-173 (1991).
211. Brusselle, G.G. et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 24, 73-80 (1994).
212. Takeda, K. et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186, 449-454 (1997).
213. Becker, M. et al. Genetic variation determines mast cell functions in experimental asthma. J. Immunol. 186, 7225-7231 (2011).
214. Yang, M., Kumar, R.K. & Foster, P.S. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-g and TLR4/MyD88 pathways. J. Immunol. 182, 5107-5115 (2009).
215. Li, J.J. et al. IL-27/IFN-γ induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J. Immunol. 185, 4401-4409 (2010).
216. Hunter, C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-531 (2005).
217. Bullens, D.M.A. et al. IL-17mRNAin sputumof asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7, 135 (2006).
218. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011).
219. Tan, B.B., Weald, D., Strickland, I. & Friedmann, P.S. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 347, 15-18 (1996).
220. He, R., Oyoshi, M.K., Jin, H. & Geha, R.S. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. USA 104, 15817-15822 (2007).
221. Hellings, P.W. et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28, 42-50 (2003).
222. Lin, A.M. et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187, 490-500 (2011).
223. Suurmond, J. et al. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res. Ther. 13, R150 (2011).
224. Préfontaine, D. et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J. Allergy Clin. Immunol. 125, 752-754 (2010).
225. Préfontaine, D. et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094-5103 (2009).
226. Gudbjartsson, D.F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342-347 (2009).
227. Moffatt, M.F. et al. A large-scale, consortium-based genomewide association study of asthma. N Engl. J. Med. 363, 1211-1221 (2010).
228. Torgerson, D.G. et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat. Genet. 43, 887-892 (2011).
229. Pecaric-Petkovic, T., Didichenko, S.A., Kaempfer, S., Spiegl, N. & Dahinden, C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113, 1526-1534 (2009).
230. Yagami, A. et al. IL-33 mediates inflammatory responses in human lung tissue cells. J. Immunol. 185, 5743-5750 (2010).
231. Junttila, I.S. et al. Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. J. Allergy Clin. Immunol. 132, 704-712. e710 (2013).
232. Liew, F.Y., Pitman, N.I. & McInnes, I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110 (2010).
233. Jung, M.-Y. et al. IL-33 induces a hyporesponsive phenotype in human and mouse mast cells. J. Immunol. 190, 531-538 (2013).
234. Waern, I. et al. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. J. Immunol. 183, 6369-6376 (2009).
235. Waern, I., Lundequist, A., Pejler, G. & Wernersson, S. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol. 6, 911-920 (2013).
236. Sicherer, S.H. & Sampson, H.A. Food allergy: recent advances in pathophysiology and treatment. Annu. Rev. Med. 60, 261-277 (2009).
237. Bock, S.A., Munoz-Furlong, A. & Sampson, H.A. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 107, 191-193 (2001).
238. Bock, S.A., Munoz-Furlong, A. & Sampson, H.A. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J. Allergy Clin. Immunol. 119, 1016-1018 (2007).
239. Finkelman, F.D. Anaphylaxis: lessons from mousemodels. J. Allergy Clin. Immunol. 120, 506-515. quiz 516-507 (2007).
240. Tsujimura, Y. et al. Basophils play a pivotal role in immunoglobulin-Gmediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 28, 581-589 (2008).
241. Jonsson, F. et al. Mouse and human neutrophils induce anaphylaxis. J. Clin. Invest. 121, 1484-1496 (2011).
242. Sun, J. et al. Impact of CD40 ligand, B cells, and mast cells in peanutinduced anaphylactic responses. J. Immunol. 179, 6696-6703 (2007).
243. Reber, L.L. et al. Selective ablation of mast cells or basophils reduces peanut-induced anaphylaxis in mice. J. Allergy Clin. Immunol. 132, 881-888. e1-11 (2013).
244. Arias, K. et al. Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. J. Allergy Clin. Immunol. 127, 1552-1561. e1551 (2011).
245. Smit, J.J. et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. PLoS One 6, e28917 (2011).
246. Khodoun, M. et al. Peanuts can contribute to anaphylactic shock by activating complement. J. Allergy Clin. Immunol. 123, 342-351 (2009).
247. Ghosh, S., Hoselton, S.A. & Schuh, J.M. μ-Chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J. Immunol. 189, 1322-1329 (2012).
248. Orinska, Z. et al. Novel B cell population producing functional IgG in the absence of membrane IgM expression. Eur. J. Immunol. 32, 3472-3480 (2002).
249. Perona-Wright, G. et al. Cutting edge: Helminth infection induces IgE in the absence of mu-or delta-chain expression. J. Immunol. 181, 6697-6701 (2008).
250. Simons, F.E. Anaphylaxis: recent advances in assessment and treatment. J. Allergy Clin. Immunol. 124, 625-636. quiz 637-628 (2009).
251. Vadas, P. et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl. J. Med. 358, 28-35 (2008).
252. Vadas, P., Perelman, B. & Liss, G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J. Allergy Clin. Immunol. 131, 144-149 (2013).
253. Cheifetz, A. et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am. J. Gastroenterol. 98, 1315-1324 (2003).
254. Sampson, H.A. et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J. Allergy Clin. Immunol. 117, 391-397 (2006).
255. Bischoff, S. & Crowe, S.E. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 128, 1089-1113 (2005).
256. Hogan, S.P., Wang, Y.H., Strait, R. & Finkelman, F.D. Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity. Semin. Immunopathol. 34, 643-653 (2012).
257. Caffarelli, C., Romanini, E., Caruana, P., Street, M.E. & de' Angelis, G. Clinical food hypersensitivity: the relevance of duodenal immunoglobulin E-positive cells. Pediatr. Res. 44, 485-490 (1998).
258. Nolte, H., Schiotz, P.O., Kruse, A. & Stahl Skov, P. Comparison of intestinal mast cell and basophil histamine release in children with food allergic reactions. Allergy 44, 554-565 (1989).
259. Wang, M. et al. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-Fc∈RI-IL-13 pathway. J. Allergy Clin. Immunol. 126, 306-316. 316 e301-312 (2010).
260. Forbes, E.E. et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J. Exp. Med. 205, 897-913 (2008).
261. Boyce, J.A. et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr. Res. 31, 61-75 (2011).
262. Rance, F. Food allergy in children suffering from atopic eczema. Pediatr. Allergy Immunol. 19, 279-284; quiz 285 (2008).
263. Noti, M. et al. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J. Allergy Clin. Immunol. 133, 1390-1399. 1399 e1391-1396 (2014).
264. Burton, O.T. et al. Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells. Immunity 41, 141-151 (2014).
265. Choi, H.W. & Abraham, S.N. Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms. Mol. Immunol. 63, 74-79 (2015).
266. Chan, C.Y., St John, A.L. & Abraham, S.N. Plasticity in mast cell responses during bacterial infections. Curr. Opin. Microbiol. 15, 78-84 (2012).
267. Kumar, V. & Sharma, A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol. Immunol. 48, 14-25 (2010).
268. Galli, S.J. & Tsai, M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 40, 1843-1851 (2010).
269. Woodbury, R.G., Miller, H.R., Huntley, J.F., Newlands, G.F., Palliser, A.C. & Wakelin, D. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature 312, 450-452 (1984).
270. Askenase, P.W. Immune inflammatory responses to parasites: the role of basophils, mast cells and vasoactive amines. Am. J. Trop. Med. Hyg. 26, 96-103 (1977).
271. Knight, P.A., Wright, S.H., Lawrence, C.E., Paterson, Y.Y. & Miller, H.R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192, 1849-1856 (2000).
272. Barrett, K.E. et al. The immune response to nematode parasites: modulation of mast cell numbers and function during Strongyloides stercoralis infections in nonhuman primates. Am. J. Trop. Med. Hyg. 38, 574-581 (1988).
273. Gustowska, L., Ruitenberg, E.J., Elgersma, A. & Kociecka, W. Increase of mucosal mast cells in the jejunum of patients infected with Trichinella spiralis. Int. Arch. Allergy Appl. Immunol. 71, 304-308 (1983).
274. Allen, J.E. & Maizels, R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 11, 375-388 (2011).
275. Grencis, R.K., Humphreys, N.E. & Bancroft, A.J. Immunity to gastrointestinal nematodes: mechanisms and myths. Immunol. Rev. 260, 183-205 (2014).
276. Maizels, R.M., Pearce, E.J., Artis, D., Yazdanbakhsh, M. & Wynn, T.A. Regulation of pathogenesis and immunity in helminth infections. J. Exp. Med. 206, 2059-2066 (2009).
277. Taylor, M.D., van der Werf, N. & Maizels, R.M. Tcells in helminth infection: the regulators and the regulated. Trends Immunol. 33, 181-189 (2012).
278. Ohnmacht, C. & Voehringer, D. Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J. Immunol. 184, 344-350 (2010).
279. v mice. J. Parasitol. 69, 66-69 (1983).
280. V mice by adoptive transfer of bone marrow-derived cultured mast cells and its effects on the protective capacity to Strongyloides ratti-infection. Parasite Immunol. 9, 31-38 (1987).
281. Sasaki, Y. et al. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J. Exp. Med. 202, 607-616 (2005).
282. Khan, A.I., Horii, Y. & Nawa, Y. Defective mucosal immunity and normal systemic immunity of Mongolian gerbils, Meriones unguiculatus, to reinfection with Strongyloides venezuelensis. Parasite Immunol. 15, 565-571 (1993).
283. v mice. Infect. Immun. 41, 445-447 (1983).
284. v mice reconstituted with haematopoietic and lymphopoietic cells and origin of mucosal mast cells. Immunology 53, 337-344 (1984).
285. Koyama, K. & Ito, Y. Mucosal mast cell responses are not required for protection against infection with the murine nematode parasite Trichuris muris. Parasite Immunol. 22, 13-20 (2000).
286. Hepworth, M.R. et al. Mast cells orchestrate type 2 immunity to helminths through regulation of tissue-derived cytokines. Proc. Natl. Acad. Sci.USA 109, 6644-6649 (2012).
287. v mice after reconstitution with bone marrow cells or cultured mast cells, and its relation to the protective capacity to Strongyloides ratti infection. Parasite Immunol. 9, 477-485 (1987).
288. W-v mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab. Invest. 85, 388-396 (2005).
289. Shin, K. et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180, 4885-4891 (2008).
290. + regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice. PLoS Pathog. 10, e1003913 (2014).
291. Newlands, G.F., Miller, H.R., MacKellar, A. & Galli, S.J. Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. Blood 86, 1968-1976 (1995).
292. Arizono, N. et al. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats. Blood 81, 2572-2578 (1993).
293. Townsend, J.M., Fallon, G.P., Matthews, J.D., Smith, P., Jolin, E.H. & McKenzie, N.A. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573-583 (2000).
294. Harris, N. & Gause, W.C. To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol. 32, 80-88 (2011).
295. Pritchard, D.I. Immunity to helminths: is too much IgE parasite-rather than host-protective? Parasite Immunol. 15, 5-9 (1993).
296. Wakelin, D. Immunity to intestinal parasites. Nature 273, 617-620 (1978).
297. Zhu, D., Kepley, C.L., Zhang, M., Zhang, K. & Saxon, A. A novel human immunoglobulin FcγFc∈ bifunctional fusion protein inhibits Fc∈RI-mediated degranulation. Nat. Med. 8, 518-521 (2002).
298. Zhu, D., Kepley, C.L., Zhang, K., Terada, T., Yamada, T. & Saxon, A. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat. Med. 11, 446-449 (2005).
299. Echtenacher, B., Mannel, D.N. & Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
300. Maurer, M. et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343-2348 (1998).
301. Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004).
302. Mallen-St Clair, J., Pham, C.T., Villalta, S.A., Caughey, G.H. & Wolters, P.J. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J. Clin. Invest. 113, 628-634 (2004).
303. Piliponsky, A.M. et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat. Med. 14, 392-398 (2008).
304. Sutherland, R.E., Olsen, J.S., McKinstry, A., Villalta, S.A. & Wolters, P.J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol. 181, 5598-5605 (2008).
305. Piliponsky, A.M. et al. The chymase mousemast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis. Am. J. Pathol. 181, 875-886 (2012).
306. Nakano, N. et al. Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 109, 4846-4855 (2007).
307. Kanamaru, Y., Sumiyoshi, K., Ushio, H., Ogawa, H., Okumura, K. & Nakao, A. Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis. J. Immunol. 174, 4193-4197 (2005).
308. Orinska, Z. et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13, 927-934 (2007).
309. Huang, C. et al. Evaluation of the substrate specificity of human mast cell tryptase βI and demonstration of its importance in bacterial infections of the lung. J. Biol. Chem. 276, 26276-26284 (2001).
310. Thakurdas, S.M. et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 282, 20809-20815 (2007).
311. Xu, X. et al. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 173, 219-225 (2006).
312. Wershil, B.K., Castagliuolo, I. & Pothoulakis, C. Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 114, 956-964 (1998).
313. Malaviya, R., Navara, C. & Uckun, F.M. Role of Janus kinase 3 inmast cellmediated innate immunity against gram-negative bacteria. Immunity 15, 313-321 (2001).
314. Anderson, G.G., Dodson, K.W., Hooton, T.M. & Hultgren, S.J. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12, 424-430 (2004).
315. Shelburne, C.P. et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 6, 331-342 (2009).
316. Malaviya, R., Ikeda, T., Abraham, S.N. & Malaviya, R. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol. Lett. 91, 103-111 (2004).
317. Chan, C.Y., St John, A.L. & Abraham, S.N. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38, 349-359 (2013).
318. + regulatory T cells. Blood 122, 3659-3665 (2013).
319. Ronnberg, E. et al. Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo. Immunology 143, 155-163 (2014).
320. Sugiyama, K. Histamine release from rat mast cells induced by Sendai virus. Nature 270, 614-615 (1977).
321. Castleman, W.L., Sorkness, R.L., Lemanske, R.F. Jr. & McAllister, P.K. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am. J. Pathol. 137, 821-831 (1990).
322. Sorden, S.D. & Castleman, W.L. Virus-induced increases in bronchiolar mast cells in Brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab. Invest. 73, 197-204 (1995).
323. Kulka, M., Alexopoulou, L., Flavell, R.A. & Metcalfe, D.D. Activation of mast cells by double-stranded RNA: evidence for activation through Tolllike receptor 3. J. Allergy Clin. Immunol. 114, 174-182 (2004).
324. + T-cell recruitment. Blood 106, 978-987 (2005).
325. Higuchi, H. et al. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 118, 363-372 (2008).
326. Zsebo, K.M. et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63, 213-224 (1990).
327. Wang, Z. et al. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J. Immunol. 188, 345-357 (2012).
328. Wang, Z., MacLeod, D.T. & Di Nardo, A. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J. Immunol. 189, 1551-1558 (2012).
329. St John, A.L., Rathore, A.P., Raghavan, B., Ng, M.L. & Abraham, S.N. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife 2, e00481 (2013).
330. St John, A.L. Influence of mast cells on dengue protective immunity and immune pathology. PLoS Pathog. 9, e1003783 (2013).
331. St John, A.L. et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. USA 108, 9190-9195 (2011).
332. Ebert, S. et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog. 10, e1004100 (2014).
333. Sundstrom, J.B. et al. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109, 5293-5300 (2007).
334. Bannert, N. et al. Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J. Virol. 75, 10808-10814 (2001).
335. Sundstrom, J.B., Little, D.M., Villinger, F., Ellis, J.E. & Ansari, A.A. Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172, 4391-4401 (2004).
336. Li, Y. et al. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 97, 3484-3490 (2001).
337. McLachlan, J.B. et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat. Med. 14, 536-541 (2008).
338. Ferry, X., Brehin, S., Kamel, R. & Landry, Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 23, 1507-1515 (2002).
339. Aridor, M., Rajmilevich, G., Beaven, M.A. & Sagi-Eisenberg, R. Activation of exocytosis by the heterotrimeric G protein Gi3. Science 262, 1569-1572 (1993).
340. Paton, W.D. Compound 48/80: a potent histamine liberator. Br. J. Pharmacol. Chemother. 6, 499-508 (1951).
341. Fawcett, D.W. Cytological and pharmacological observations on the release of histamine by mast cells. J. Exp. Med. 100, 217-224 (1954).
342. Rothschild, A.M. Mechanisms of histamine release by compound 48-80. Br. J. Pharmacol. 38, 253-262 (1970).
343. Gushchin, I.S., Miroshnikov, A.I., Martynov, V.I. & Sviridov, V.V. Histamine releasing and anti-inflammatory activities of MCD-peptide and its modified forms. Agents Actions 11, 69-71 (1981).
344. Galli, S.J., Wershil, B.K., Bose, R., Walker, P.A. & Szabo, S. Ethanolinduced acute gastric injury in mast cell-deficient and congenic normal mice. Evidence that mast cells can augment the area of damage. Am. J. Pathol. 128, 131-140 (1987).
345. Pae, S., Cho, J.Y., Dayan, S., Miller, M., Pemberton, A.D. & Broide, D.H. Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics 62, 499-506 (2010).
346. Xing, W., Austen, K.F., Gurish, M.F. & Jones, T.G. Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue. Proc. Natl. Acad. Sci. USA 108, 14210-14215 (2011).
347. Forsberg, E. et al. Abnormal mast cells in mice deficient in a heparinsynthesizing enzyme. Nature 400, 773-776 (1999).
348. Humphries, D.E. et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400, 769-772 (1999).
349. Rönnberg, E., Melo, F.R. & Pejler, G. Mast cell proteoglycans. J. Histochem. Cytochem. 60, 950-962 (2012).
350. Schwartz, L.B. Mast cells: function and contents. Curr. Opin. Immunol. 6, 91-97 (1994).
351. Craig, S.S., Irani, A.M., Metcalfe, D.D. & Schwartz, L.B. Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold. Lab. Invest. 69, 552-561 (1993).
352. Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nat. Rev. Immunol. 14, 478-494 (2014).
353. Wong, G.W. et al. Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOHterminal hydrophobic extension. J. Biol. Chem. 274, 30784-30793 (1999).
354. Xia, H.Z., Kepley, C.L., Sakai, K., Chelliah, J., Irani, A.M. & Schwartz, L.B. Quantitation of tryptase, chymase, Fc∈RIα, and Fc∈RIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. 154, 5472-5480 (1995).
355. Caughey, G.H. et al. Characterization of human γ-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J. Immunol. 164, 6566-6575 (2000).
356. TC type of human mast cell. J. Immunol. 145, 2652-2661 (1990).
357. Irani, A.M., Goldstein, S.M., Wintroub, B.U., Bradford, T. & Schwartz, L.B. Human mast cell carboxypeptidase. Selective localization to MCTC cells. J. Immunol. 147, 247-253 (1991).
358. Vanderslice, P., Ballinger, S.M., Tam, E.K., Goldstein, S.M., Craik, C.S. & Caughey, G.H. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. USA 87, 3811-3815 (1990).
359. Katz, H.R., Stevens, R.L. & Austen, K.F. Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J. Allergy Clin. Immunol. 76, 250-259 (1985).
360. Li, H.J. et al. Distinct cellular origins for serotonin-expressing and enterochromaffin-like cells in the gastric corpus. Gastroenterology 146, 754-764. e753 (2014).
361. von Stebut, E., Metz, M., Milon, G., Knop, J. & Maurer, M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα. Blood 101, 210-215 (2003).
362. Kushnir-Sukhov, N.M., Brown, J.M., Wu, Y., Kirshenbaum, A. & Metcalfe, D.D. Humanmast cells are capable of serotonin synthesis and release. J. Allergy Clin. Immunol. 119, 498-499 (2007).
363. Lowman, M.A., Rees, P.H., Benyon, R.C. & Church, M.K. Human mast cell heterogeneity: histamine release frommast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J. Allergy Clin. Immunol. 81, 590-597 (1988).
364. 3 adenosine receptor and inflammation. Front. Immunol. 3, 134 (2012).
365. Zhong, H. et al. Activation of murine lung mast cells by the adenosine A3 receptor. J. Immunol. 171, 338-345 (2003).
366. 3 receptors on mast cells. J. Clin. Invest. 105, 361-367 (2000).
367. Sereda, M.J., Bradding, P. & Vial, C. Adenosine potentiates human lung mast cell tissue plasminogen activator activity. J. Immunol. 186, 1209-1217 (2011).
368. Gomez, G., Zhao, W. & Schwartz, L.B. Disparity in Fc∈RI-induced degranulation of primary human lung and skin mast cells exposed to adenosine. J. Clin. Immunol. 31, 479-487 (2011).
369. Ujike, A. et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J. Exp. Med. 189, 1573-1579 (1999).
370. Takai, T., Ono, M., Hikida, M., Ohmori, H. & Ravetch, J.V. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379, 346-349 (1996).
371. Hazenbos, W.L. et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5, 181-188 (1996).
372. Dombrowicz, D., Flamand, V., Miyajima, I., Ravetch, J.V., Galli, S.J. & Kinet, J.P. Absence of Fc∈RI α chain results in upregulation of FcγRIII dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc∈RI and FcγRIII for limiting amounts of FcR β and γ chains. J. Clin. Invest. 99, 915-925 (1997).
373. Coleman, J.W. & Godfrey, R.C. The number and affinity of IgE receptors on dispersed human lung mast cells. Immunology 44, 859-863 (1981).
374. Sellge, G. et al. Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells. BMC Immunol. 15, 27 (2014).
375. Helm, B., Marsh, P., Vercelli, D., Padlan, E., Gould, H. & Geha, R. The mast cell binding site on human immunoglobulin E. Nature 331, 180-183 (1988).
376. Tkaczyk, C., Okayama, Y., Woolhiser, M.R., Hagaman, D.D., Gilfillan, A.M. & Metcalfe, D.D. Activation of human mast cells through the high affinity IgG receptor. Mol. Immunol. 38, 1289-1293 (2002).
377. Zhao, W., Kepley, C.L., Morel, P.A., Okumoto, L.M., Fukuoka, Y. & Schwartz, L.B. FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells. J. Immunol. 177, 694-701 (2006).
378. Trivedi, N.N., Tamraz, B., Chu, C., Kwok, P.Y. & Caughey, G.H. Human subjects are protected frommast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. J. Allergy Clin. Immunol. 124, 1099-1105. e1091-1094 (2009).
379. Befus, A.D., Pearce, F.L., Gauldie, J., Horsewood, P. & Bienenstock, J. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells. J. Immunol. 128, 2475-2480 (1982).
380. Katz, H.R. & Lobell, R.B. Expression and function of FcγR inmouse mast cells. Int. Arch. Allergy Immunol. 107, 76-78 (1995).